Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $147,549 | 83 | 72.4% |
| Food and Beverage | $33,140 | 1,424 | 16.3% |
| Consulting Fee | $11,171 | 7 | 5.5% |
| Travel and Lodging | $10,077 | 88 | 4.9% |
| Honoraria | $1,700 | 1 | 0.8% |
| Education | $291.05 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $62,802 | 232 | $0 (2022) |
| Amgen Inc. | $37,928 | 82 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $37,869 | 155 | $0 (2024) |
| ABBVIE INC. | $32,248 | 272 | $0 (2024) |
| Lilly USA, LLC | $13,965 | 60 | $0 (2024) |
| Lundbeck LLC | $3,072 | 68 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $1,094 | 42 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,055 | 57 | $0 (2024) |
| MDD US Operations, LLC | $843.95 | 14 | $0 (2024) |
| PFIZER INC. | $814.82 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,512 | 185 | Lundbeck LLC ($2,061) |
| 2023 | $10,848 | 201 | AbbVie Inc. ($7,011) |
| 2022 | $18,215 | 191 | ABBVIE INC. ($14,497) |
| 2021 | $28,268 | 202 | Teva Pharmaceuticals USA, Inc. ($9,751) |
| 2020 | $32,893 | 142 | Allergan, Inc. ($21,995) |
| 2019 | $49,308 | 249 | Allergan Inc. ($14,635) |
| 2018 | $36,847 | 196 | Amgen Inc. ($15,196) |
| 2017 | $22,038 | 247 | Allergan Inc. ($11,231) |
All Payment Transactions
1,613 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Insomnia | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: CNS | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $1,700.00 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Neuromodulation | ||||||
| 11/26/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology and Neurology | ||||||
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: AMANTADINE | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $90.42 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $73.44 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: PAIN | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.64 | General |
| 11/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $2.59 | General |
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: Neurology | ||||||
| 11/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 430 | 22,438 | $598,415 | $229,161 |
| 2022 | 10 | 323 | 20,792 | $518,900 | $210,532 |
| 2021 | 9 | 363 | 18,935 | $509,500 | $201,291 |
| 2020 | 12 | 454 | 16,851 | $428,660 | $167,265 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 21,001 | $247,140 | $102,330 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 532 | $159,500 | $60,819 | 38.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 38 | 227 | $45,400 | $17,462 | 38.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 31 | 104 | $31,200 | $15,324 | 49.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 39 | 171 | $42,750 | $10,515 | 24.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 107 | $21,400 | $4,734 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 27 | $9,450 | $4,518 | 47.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 75 | $15,000 | $4,399 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 52 | $10,400 | $4,357 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $5,950 | $3,548 | 59.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $2,325 | $646.29 | 27.8% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 19 | 29 | $7,250 | $391.38 | 5.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 13 | 24 | $240.00 | $117.60 | 49.0% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 12 | 41 | $410.00 | $0.82 | 0.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 31 | 19,700 | $236,400 | $96,497 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 505 | $151,500 | $61,432 | 40.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 39 | 211 | $42,200 | $17,340 | 41.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 31 | 98 | $29,400 | $16,316 | 55.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 34 | 126 | $31,500 | $8,223 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 38 | $13,300 | $6,627 | 49.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,550 | $2,802 | 61.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 40 | 40 | $3,000 | $893.65 | 29.8% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2022 | 13 | 20 | $5,000 | $290.81 | 5.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 17 | 41 | $2,050 | $111.46 | 5.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 27 | 17,703 | $212,400 | $85,960 | 40.5% |
About Dr. Randall Berliner, MD
Dr. Randall Berliner, MD is a Specialist healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962469809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randall Berliner, MD has received a total of $203,928 in payments from pharmaceutical and medical device companies, with $5,512 received in 2024. These payments were reported across 1,613 transactions from 81 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($147,549).
As a Medicare-enrolled provider, Berliner has provided services to 1,570 Medicare beneficiaries, totaling 79,016 services with total Medicare billing of $808,249. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Psychiatry, Neurology
- Location Bronx, NY
- Active Since 04/26/2006
- Last Updated 10/24/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962469809
Products in Payments
- UBRELVY (Drug) $35,232
- BOTOX (Biological) $29,600
- Aimovig (Biological) $26,623
- AJOVY (Biological) $19,680
- AJOVY (Drug) $17,313
- BOTOX (Drug) $14,205
- QULIPTA (Drug) $6,990
- BOTOX CHRONIC MIGRAINE (Drug) $6,693
- VYEPTI (Biological) $2,223
- VRAYLAR (Drug) $1,286
- REXULTI (Drug) $1,088
- NUEDEXTA (Drug) $785.25
- RYTARY (Drug) $731.04
- NURTEC ODT (Drug) $619.89
- MYOBLOC (Drug) $577.80
- KESIMPTA (Drug) $572.71
- EMGALITY (Drug) $517.86
- TRINTELLIX (Drug) $404.64
- GOCOVRI (Drug) $395.61
- CAPLYTA (Drug) $390.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bronx
Mahmood Kazmi
Specialist — Payments: $186,504
Dr. Peter Barland, M.d, M.D
Specialist — Payments: $85,232
Dr. Evan Garfein, Md, MD
Specialist — Payments: $75,467
Dr. Ghazanfar Abdullah, Md, MD
Specialist — Payments: $42,101
Karen Hennessey, M.d, M.D
Specialist — Payments: $30,727
Dr. Sireen Gopal, M.d, M.D
Specialist — Payments: $14,139